National Bank Of Canada Intercept Pharmaceuticals, Inc. Transaction History

National Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$9.17 - $19.29 $550 - $1,157	60 Added 63.16%	155 $1,000
Q4 2022 Jan 24, 2023	BUY	$11.61 - $16.11 $464 - $644	40 Added 72.73%	95 $0
Q4 2021 Jan 24, 2022	BUY	$14.28 - $19.53 $785 - $1,074	55 New	55 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.